Low-dose bortezomib increases the expression of NKG2D and DNAM-1 ligands and enhances induced NK and γδ T cell-mediated lysis in multiple myeloma

Multiple myeloma (MM) is an incurable hematological malignancy, although bortezomib has markedly improved its outcomes. Growing clinical evidence indicates that enhancing induced natural killer (NK) or γδ T cells for infusion is useful in the treatment of MM. However, whether combination treatment w...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Chao, Jin, Haofan, Li, Min, Zhu, Shan, Zhou, Lei, Jin, Feng, Zhou, Yulai, Xu, Dongsheng, Xu, Jianting, Zhao, Lianjing, Hao, Shanshan, Li, Wei, Cui, Jiuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351604/
https://www.ncbi.nlm.nih.gov/pubmed/27992381
http://dx.doi.org/10.18632/oncotarget.13979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351604/
https://www.ncbi.nlm.nih.gov/pubmed/27992381
http://dx.doi.org/10.18632/oncotarget.13979

Ejemplares similares